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The Friend or Moloney mink cell focus-forming (MCF) virus encodes a recombinant-type envelope
glycoprotein, gp7O, that is closely related to the membrane glycoprotein, gp55, of Friend spleen focus-forming
virus (SFFV). We have shown previously that gp55 has the ability to activate cell growth by binding to the
cellular receptor for erythropoietin. Here we show that gp7O encoded by either the Friend or Moloney MCF
virus also binds to the erythropoietin receptor and that coexpression of the receptor and gp7O in an
interleukin-3 (IL-3)-dependent cell line can activate IL-3-independent growth. Furthermore, when the cDNA
for the human IL-2 receptor ,I chain, which is related by sequence to the erythropoietin receptor, was
introduced into this cell line, it became growth factor independent after infection either with SFFV or with one
of the two MCF viruses but not with an ecotropic virus. Based on these observations, we propose a mechanism
for the early stage of leukemogenesis induced by the MCF-type murine leukemia viruses.
There is a class of murine leukemia viruses (MuLVs) that
have a characteristic envelope glycoprotein (gp70) that al-
lows infection of cells from many species. They transform
mink cells and are called mink cell focus-forming (MCF)
viruses (29). Many murine-tropic viruses convert to MCF
viruses in animals by recombination in the env region with
endogeneous MCF virus-type sequences (7, 9, 21, 23, 49,
56). Particularly relevant to the present work is that the
spleen focus-forming viruses (SFFVs) encode a glycopro-
tein, gp55 that is a truncated form of MCF gp7O (2, 5, 15, 65).
Various MCF viruses have been isolated from a variety of
spontaneous and virus or non-virus-induced leukemias and
lymphomas, including spontaneous lymphomas of AKR (16,
29) or HRS/J (27) mice; ecotropic Friend MuLV-, Rauscher
MuLV (R-MuLV)-, or Moloney MuLV-induced leukemias
or lymphomas (14, 22, 51, 59, 61, 62); X-ray induced
lymphomas (28); and graft-versus-host-induced reticulum
cell neoplasms (3). Some of the MCF viruses are potent
leukemogens, and they cause tissue-specific neoplasms
when injected into susceptible newborn mice (14, 32, 61).
Others can accelerate the leukemogenic process in mice with
high incidence of spontaneous leukemias (16). The mecha-
nism of leukemogenesis induced by the various MCF viruses
is not known.
Previous studies of several cloned MCF virus genomes
revealed extensive sequence identities in their amino-termi-
nal env regions (1, 8, 34, 35, 63). Recombinations between
the nonleukemogenic amphotropic virus 4070 and leuke-
mogenic Friend MCF (F-MCF) virus have shown that, in
addition to the long terminal repeat (LTR) sequences, the
env gene of F-MCF virus is required for leukemogenicity
(48). Further studies have established that the tissue speci-
ficities of many virus-induced diseases are determined by
sequence elements in the LTRs of the viral genomes (11, 12,
25, 33, 40, 63).
Friend SFFV causes an acute erythroleukemia in adult
mice (24, 41, 58). SFFV gpS5 encoded by the recombinant-
type env gene (57) is directly involved in leukemogenesis (37,
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38, 43, 52). Sequence analyses of the env genes from several
different SFFVs have indicated that they all contain a
5'-terminal region highly homologous to the MCF virus env
sequences and that they may actually be derived from the
MCF virus env gene through a major deletion and some point
mutations (2, 5, 15, 65). There is evidence that SFFV gpS5
binds to the cellular receptor for MCF viruses and that this
binding interferes with MCF virus superinfection (13, 38).
We have shown previously that SFFV gpS5 binds to the
cellular receptor for erythropoietin (Epo-R) and that this
interaction can activate cell growth (39). This provides a
plausible explanation for how the viral protein may cause a
prolonged proliferation of the infected erythroid cells, which
may eventually lead to the activation of an additional cellular
oncogene(s) (47) and to the development of leukemia. Be-
cause Epo-R appears to belong to a family of growth factor
receptors (4, 18, 19), including the recently cloned human
interleukin-2 (IL-2) receptor , chain (IL-2R,B) (31), it is
possible that the recombinant-type viral glycoproteins inter-
act with various members of this receptor family which are
expressed during certain stages of hematopoiesis in various
target cells, causing a prolonged proliferation of these cells
in the preleukemic stage.
Here we show that the gp70 encoded by either the F-MCF
or Moloney MCF (M-MCF) virus, like the SFFV gpS5, binds
to Epo-R and that this interaction can activate growth
factor-independent proliferation of an IL-3-dependent lym-
phoid cell line. Furthermore, when coexpressed with IL-
2Rf, these glycoproteins can also activate cell growth. We
propose a general model for leukemogenesis induced by the
MCF virus-type MuLVs involving growth factor receptor-
mediated proliferation.
MATERIALS AND METHODS
Cell culture and virus infection. Mouse NIH 3T3 fibroblast
cells were maintained in Dulbecco's modified Eagle medium
supplemented with 10% calf serum, and IL-3-dependent
pro-B lymphoid Ba/F3 cells (44) were grown in RPMI plus
10% fetal bovine serum and 10% WEHI-3 supernatant as a
source of IL-3. For virus infection, about 5 x 105 to 2 x 106
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cells were mixed with 2 to 5 ml of various supernatants
collected from virus-producing fibroblasts immediately be-
fore infection. Polybrene (8 ,ug/ml; Sigma) was added to
facilitate the infection. After 4 h of incubation at 37°C, fresh
medium containing IL-3 was added, and the cultures were
kept for 48 h before they were switched to medium without
any added growth factors or with IL-2 (2 U/ml; Boehringer
Mannheim), Epo (0.5 U/ml; Amgen), or IL-3 as control.
After 1 week of incubation at 37°C, the infected cells were
cloned by limiting dilution. R-MuLV was produced from the
Rwt NIH 3T3 line (38), and Friend SFFV was produced from
fibroblast packaging cells after they were transfected with a
molecular clone (42) of the Lilly-Steeves polycythemia
strain.
Plasmid construction and DNA transfection. The plasmid
pIL-2R,30, which contains cDNA or human IL-2R1 (31),
was a gift from T. Taniguchi. A DNA fragment encompass-
ing the coding sequence for IL-2RP was engineered to be
compatible with BamHI-EcoRI sites and was cloned into
retroviral vector pSFF (6) through these sites. The resulting
plasmid, pSF-I2RP, was transfected into a mixture of psi-cre
and psi-crip packaging cells (20) by calcium precipitation
(26), and virus containing the IL-2R,B cDNA sequence was
obtained from the culture supernatant after 2 weeks of
cocultivation according to the previously described method
(6). The molecular clone of either F-MCF virus (plasmid
pFr-MCF1310) (1) or M-MCF virus (plasmid pMo-MCF-I)
(8) was transfected into NIH 3T3 cells, and the correspond-
ing virus was obtained from the culture supernatant 2 weeks
later.
IP. The general method of immunoprecipitation (IP) was
described previously (53). For double IP, the [355]methio-
nine (50 pLC/ml; New England Nuclear)-labeled cells were
lysed with IP buffer (20 mM Tris [pH 7.4], 0.1% sodium
dodecyl sulfate [SDS], 1% Triton X-100, 0.5% sodium de-
oxycholate, 0.5 M NaCl, 1 mM EDTA), and the protein
extracts were precleared of cell debris by ultracentrifugation
(Beckman TL-100; 90,000 rpm for 10 min). After the first IP
with an anti R-MuLV gp7O antiserum (National Cancer
Institute) which cross-reacts with both SFFV gp55 and MCF
virus gp7O, the IP pellets were resuspended in 0.05 ml of
loading buffer (60 mM Tris [pH 6.8], 2% SDS, 10% glycerol,
1% 2-mercaptoethanol) and heated at 100°C for 10 min. After
a brief microcentrifugation, the supernatants were diluted
1:20 with IP buffer and subjected to a second IP using an anti
Epo-R antiserum (39). Anti-IL-2RP IP was carried out with
the anti-human IL-2R1 monoclonal antibody Mik-i1 (31),
generously provided by M. Tsudo. Protein samples from the
IP pellets were analyzed by electrophoresis through 12.5%
SDS-polyacrylamide gels.
RESULTS
MCF virus envelope glycoproteins bind to Epo-R. To deter-
mine whether the MCF virus envelope glycoproteins could
bind to Epo-R, we infected the cell line ER-1, a fibroblast
subclone that expresses a high level of Epo-R (39), with
either F-MCF or M-MCF virus. IP with anti-gp7O showed a
high level of gp7O expression after infection (Fig. 1A, lanes 1
and 2, for F-MCF virus- or M-MCF virus-infected ER-1
cells, respectively), and the identities of the polytropic gp7os
in these cells were confirmed by additional IP with an MCF
virus-specific monoclonal antibody (64; data not shown).
The uninfected ER-1 cells contained ecotropic gp7O (Fig. 1,
lane 3; also see reference 39).
Because of the excess of MCF virus gp7O in the IP with
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FIG. 1. SDS-polyacrylamide gel electrophoresis of [35S]methio-
nine-labeled proteins after IP. (A) Lanes 1 to 3, Single IPs by a goat
anti-R-MuLV gp7O antiserum which cross-reacts with both MCF
virus gp7O and SFFV gp55 (38); lanes 4 to 6, single IPs with
antiserum against the NH,-terminal (APSPSLPDPKFESKC) pep-
tide of the Epo-R protein (39). (B) Lanes 7 to 9, Double IPs first by
anti-gp7O antiserum and then by anti-Epo-R. Labeled proteins were
extracted from 5 x 105 ER-1 fibroblast cells without virus infection
(lanes 3, 4, and 7) or with either F-MCF virus (lanes 1, 6, and 9) or
M-MCF virus (lanes 2, 5, and 8) infection.
anti-gp7O and the close comigration of gp7O and Epo-R, it
was difficult to examine the possible coprecipitation of the
two proteins in this experiment. However, when the anti-
Epo-R antiserum which did not cross-react with the MCF
virus gp70 (data not shown) was used, it clearly showed that
both M-MCF virus gp7O (Fig. 1, lane 5) and F-MCF virus
gp7O (lane 6) could be coprecipitated with Epo-R, whereas
the ecotropic gp7O could not (lane 4; also see reference 39),
indicating that in MCF virus-infected ER-1 cells, some MCF
virus gp7O was tightly bound to Epo-R. The identities of the
two MCF virus gp70s were confirmed by the fact that the
M-MCF virus gp7O normally migrates slightly more slowly
than the F-MCF virus gp7O (compare lane 5 with lane 6; data
not shown).
To further confirm this finding, we first immunoprecipi-
tated the proteins from either uninfected or MCF virus-
infected ER-1 cells with anti-gp7O and then dissociated the
proteins that precipitated and subjected them to a second IP
with anti-Epo-R. Only Epo-R protein from ER-1 cells in-
fected with either of the MCF viruses could be recovered
from the final precipitates (Fig. 1B, lanes 8 and 9). For
uninfected ER-1 cells, no Epo-R could be detected in the
final precipitate (lane 7), presumably because the Epo-R
remained in the supernatant during the first IP with anti-
gp7O. This result, along with that presented above, shows
that the recombinant-type gp7O encoded by either F-MCF or
M-MCF virus, like SFFV gpS5 (39), interacts strongly with
Epo-R.
Binding of Epo-R by MCF virus gp7Os can activate cell
growth. To examine whether the interaction of MCF virus
gp7O and Epo-R had a growth-promoting activity, we iso-
lated a subclone from IL-3-dependent lymphoid Ba/F3 cells
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TABLE 1. Growth of Ba/F3 and Ba/F-ER cells after infection'
Cell line and Growth in medium supplemented withb:
source of
infection IL-3 Epo Nothing
Ba/F3
Mock + - -
R-MuLV + - -
F-MCF virus + - -
M-MCF virus + - -
Ba/F-ER
Mock + + -
R-MuLV + + -
SFFV + + +
F-MCF virus + + +
M-MCF virus + + +
" About 5 x 105 to 2 x 106 cells were infected with various viruses that were
harvested from supernatants of NIH 3T3-producing cells. After infection, the
cells were kept for 48 h in IL-3 (10% WEHI-3 supernatant) before being
switched to either Epo (0.5 U/ml) or regular medium without any added
growth factors.
b +, rapidly growing cells became established within 1 week of infection; -,
no viable cells were left within 3 to 4 days after infection, and no cell growth
occurred even after up to 1 month of incubation.
(44) after these cells had been infected with an Epo-R
cDNA-containing virus (39). This subclone, called Ba/F-ER,
was Epo (or IL-3) dependent for growth. When Ba/F-ER
cells were infected with either F-MCF or M-MCF virus,
about 0.05 to 0.1% of the cells could grow in the absence of
any added growth factors, while either the mock-infected or
the ecotropic R-MuLV-infected Ba/F-ER cells still required
IL-3 or Epo (Table 1). The low infectability of Ba/F3 cells by
retroviruses was reported previously (44), and we found that
a similar percentage (about 0.1%) of these cells could be
infected by either MCF virus or R-MuLV (data not shown).
The growth factor independence was observed only when
both Epo-R and one of the recombinant-type glycoproteins
were expressed in these cells: the parental Ba/F3 cells could
not be converted to growth factor independence after infec-
tion by either of the MCF viruses (Table 1) or by SFFV, as
shown previously (39). These results clearly indicate that
binding of Epo-R by the MCF gp70, like the interaction
between Epo-R and SFFV gp55, can activate cell growth.
This was further confirmed by the finding that when growth
factor-independent Ba/F-ER cells were cloned after infec-
tion with MCF viruses, all of the individual clones expressed
a high level of MCF gp7O (Fig. 2). Interestingly, many of
these clones also expressed an SFFV gp55-like protein
(lanes 2 to 7 and 9). This suggests that there may be a strong
selection for the expression of these truncated proteins
during growth factor-deprived growth of these cells (see
Discussion). Nevertheless, the fact that there were clones
that expressed MCF gp70 alone (lanes 1, 8, and 10) indicated
that the interaction of MCF gp7O with Epo-R was sufficient
to activate cell growth.
Coexpression of IL-2R,( and recombinant-type glycopro-
teins can also activate cell growth. It has been shown that
Epo-R and IL-2RP share limited amino acid sequence iden-
tities (18) and that they may belong to a family of growth
factor receptors (4, 19). Human IL-2RP is homologous to
that of mouse (31, 36), and its cDNA when introduced into
Ba/F3 cells could convert these cells to IL-2 dependence
(30). To see if IL-2RP had the ability to substitute for Epo-R
during growth factor-independent proliferation of virus-in-
fected Ba/F3 cells, we cloned human IL-2R, cDNA into the
2 3 4 5 6 7 89 10
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FIG. 2. Electrophoretic separation of labeled proteins after anti-
gp7O IP. Ba/F-ER clones were infected with F-MCF virus (lanes 1 to
3) or M-MCF virus (lanes 4 to 10).
retroviral vector pSFF (6) and introduced it into a mixture of
psi-cre and psi-crip packaging cells (20). After 2 weeks of
cocultivation, a high level of human IL-2RP was expressed
in these cells (Fig. 3, lane 2), and virus harvested from the
supernatant contained IL-2R1 cDNA sequences and was
infectious to mouse NIH 3T3 fibroblasts (data not shown).
When this virus was used to infect Ba/F3 cells, we
obtained several clones that depended on either IL-2 or IL-3
for their growth (data not shown) and expressed human
IL-2R, (Fig. 3, lanes 3 and 4). One of these clones, Ba/F-12,
was infected with various viruses and subsequently grown in
medium without any added growth factors. As shown in
Table 2, only those infected with SFFV, F-MCF virus, or
M-MCF virus could grow in the absence of growth factors.
The mock- or R-MuLV-infected cells retained absolute IL-2
(or IL-3) dependence. When factor-independent Ba/F-12
cells infected with various recombinant-type viruses were
cloned, a high level of viral glycoprotein expression was
seen in all of the individual clones (Fig. 4, lanes 2 and 3,
SFFV-infected clones; lanes 4 and 5, F-MCF virus-infected
clones; lanes 6 to 9, M-MCF virus-infected clones), while in
mock-infected Ba/F-12 cells, no such glycoprotein expres-
FIG. 3. Electrophoretic separation of labeled proteins after IP
with anti-IL-2RP. Lane 1, NIH 3T3 cells; lane 2, psi-cre-psi-crip
packaging cells after transfection with pSF-I2RP; lanes 3 and 4, two
IL-2-dependent clones of Ba/F3 cells after infection by the IL-2RP
cDNA-containing virus; lane 5, uninfected Ba/F3 cells.
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TABLE 2. Growth of Ba/F-I 2 cells after infection'
Source of Growth in medium supplemented with:
infection IL-3 IL-2 Nothing
Mock + + -
R-MuLV + + -
SFFV + + +b
F-MCF virus + + +b
M-MCF virus + + +b
a See Table 1, footnote a.
b The growth of these cells depended on cell density (see text).
sion was seen (lane 10). These results indicated that all three
recombinant-type glycoproteins had the ability to interact
with IL-2RP and activate factor-independent growth of
Ba/F3 cells.
Factor-independent growth of virus-infected Ba/F-12 cells is
density dependent. In the process of growing SFFV- or MCF
virus-infected Ba/F-12 cells, we noticed that there were cell
density requirements for the growth of these cells. This was
confirmed by limiting-dilution analysis, as shown in Table 3.
The growth of SFFV-infected Ba/F-I2 cells showed a density
requirement of about 103 cells per ml to initiate positive
growth in the absence of growth factors, while cells infected
with either of the MCF viruses required more than 105 cells
per ml to initiate positive growth. In contrast, SFFV- or
MCF virus-infected Ba/F-ER cells grew with equal efficiency
in the presence or absence of IL-3 (Table 3). These results
indicated that unlike virus-infected Ba/F-ER cells, infected
Ba/F-12 cells had a requirement for close cell contact during
factor-independent growth. This was further confirmed by
the observations that these cells formed clusters in culture
dishes and that constant dilutions caused extensive cell
death (data not shown).
DISCUSSION
Previously we showed that SFFV gp55 binds to Epo-R and
that the mitogenic effect of this binding can be demonstrated
by the ability to promote growth factor-independent prolif-
eration of lymphoid Ba/F3 cells (39). We now extend this
finding to MCF virus envelope glycoproteins by showing
that MCF gp70s have a similar activity. Furthermore, when
2 3 4 - 6 7 8 9 C
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FIG. 4. Electrophoretic separation of labeled proteins after IP
with anti-gp7O. The proteins were extracted from Ba/F-12 clones
infected with SFFV (lanes 2 and 3), F-MCF virus (lanes 4 and 5), or
M-MCF virus (lanes 6 to 9). Lane 10, Uninfected Ba/F-12 cells; lane
1, labeled protein molecular weight markers.
coexpressed with IL-2RP, both SFFV and MCF glycopro-
teins can activate proliferation of Ba/F3 cells in the absence
of growth factors. Together, these results provide evidence
for a common mechanism by which MCF-type MuLVs can
induce neoplasms because of their propensity to interact
with growth factor receptors.
We propose that in the preleukemic stage in infected
animals, there is a prolonged proliferation of infected hema-
topoietic cells due to the interaction between recombinant-
type viral glycoproteins and one member of the Epo-R-IL-
2R, growth factor receptor family that is expressed in the
specific target cells. The tissue specificity of this preleuke-
mic proliferation depends not only on the type of the infected
cells in which the viral promoter-enhancer is active, but also
on the availability of a growth factor receptor that is ex-
pressed during the normal development of those cells. For
example, the LTRs of both the SFFV and F-MCF virus
genomes contain erythroid-specific promoter-enhancer ele-
ments (12, 54), and their glycoproteins interact with Epo-R
expressed in infected erythroid precursor cells. On the other
hand, the thymotropic MCFviruses, such as M-MCF virus,
TABLE 3. Limiting-dilution analysis of infected cells
No. of wells with positive growtha/total no. of wells
Cell line andellined
~~~~~~~~~~~~~~~~~~~~~~~InRPMI + IL-3 atsource of In RPMI at dilution of: dilution of:infection
lo-, 10-2 10-3 1o-4 1O-5 10-6 1O-5 10-6
BA/F-12
Mock 0/36 0/36 0/36 0/36 NDb ND 12/24 1/24
SFFV 36/36 36/36 24/36 2/36 ND ND 15/24 1/24
F-MCF virus 17/36 1/36 0/36 0/36 ND ND 9/24 2/24
M-MCF virus 18/36 1/36 0/36 0/36 ND ND 10/24 2/24
Ba/F-ER
SFFV ND ND ND ND 31/36 8/36 33/36 4/36
F-MCF virus ND ND ND ND 24/36 3/36 22/36 4/36
M-MCF virus ND ND ND ND 20/36 5/36 20/36 3/36
a Various infected cell cultures growing at about 106/ml were diluted and put into the 96-well culture dishes at 0.1 ml per well. Two to three weeks later, wells
having viable, actively dividing cells were scored as having positive growth.
bND, Not done.
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contain lymphoid-specific promoter-enhancer elements (10),
and their glycoproteins interact with IL-2RP expressed in
infected lymphoid cells. We assume that prolonged prolifer-
ation of these infected hematopoietic cells as a result of this
glycoprotein-growth factor receptor interaction eventually
leads to the activation of an additional cellular oncogene(s)
such as Spi-1 (47) or c-myc (17, 55, 60) and thus to the
development of frank leukemia.
Several lines of evidence have suggested that the tissue
specificity of the leukemias induced by various MuLVs is
determined by the sequence elements in the LTRs of the
viral genomes. First, when part of the F-MCF virus LTR
was replaced by the sequence from the corresponding region
of the Moloney LTR, the resulting hybrid virus caused
mainly lymphoid leukemia instead of erythroleukemia (33).
Second, in Friend or Moloney MuLV-induced leukemias,
which are believed to be due to the eventual appearance of
MCF viruses in the infected animals (59, 62), the tissue
specificity of the disease was also determined by the LTR
sequence (11, 12, 40). These findings indicate that the
recombinant-type viral glycoproteins themselves do not de-
termine tissue specificity. This is consistent with our findings
that M-MCF and F-MCF virus gp70s have a similar biolog-
ical effect when coexpressed with either Epo-R or IL-2RP in
Ba/F3 cells.
SFFV gp55 seemed to have a stronger effect than MCF
virus gp70s in promoting the proliferation of Ba/F-12 cells,
because SFFV-infected cells had a lower density require-
ment for initiating positive growth in the limiting-dilution
analysis (Table 3). It is known that SFFV-induced erythro-
leukemia is more severe and that it occurs within a relatively
short period (about 2 weeks) in adult mice (24), while F-MCF
virus-induced erythroleukemia is milder and occurs several
months after infection and only in newborn animals (32). The
difference in biological activity of these viruses in vivo,
therefore, may be a direct reflection of the differences
between the effects of gp55 and gp7O in Ba/F-12 cells.
The nature of the gp55-like proteins seen in the MCF
virus-infected Ba/F-ER clones (Fig. 2) is not known. Be-
cause both of our F-MCF and M-MCF virus stocks were
obtained from mouse fibroblast cells after the cells had been
transfected with the corresponding molecular clones (1, 8)
and because the sizes of some of these proteins as judged by
their migration on SDS-polyacrylamide gels vary (Fig. 2,
compare lanes 6 and 7, for example; data not shown), it is
unlikely that these proteins are a consequence of contami-
nating SFFV genomes. It is possible that these proteins are
actually from defective viral genomes that are generated
either through deletions of the MCF virus env gene or
through recombination of the MCF virus genome with some
endogenous sequences. In any case, it seems that there is a
strong selection for the expression of these proteins during
factor-independent growth of Ba/F-ER cells. It will be of
interest to see if these potentially defective viruses resemble
SFFV and represent evolution from an MCF virus to SFFV.
It is possible that the putative cellular receptor which the
MCF viruses use to penetrate the target cell belongs to the
same receptor family as Epo-R-IL-2RP, although the MCF
virus receptor must have an entirely different tissue distri-
bution because it is expressed in mouse fibroblasts. The
virus may actually use Epo-R-IL-2RP to penetrate various
target cells in infected animals. It was reported that the
Rauscher MCF virus isolate, which could not infect mouse
NIH 3T3 fibroblasts in vitro, was fully leukemogenic when
injected into animals (63), implying that it used a different
receptor to penetrate target cells in vivo. The fact that there
are viruses that belong to the same interference group as
MCF viruses in fibroblasts yet fail to cause cytopathic foci
on mink cell monolayers (50) also seems to indicate that the
MCF viruses may use a variety of different receptors for
their penetration of target cells.
It is surprising that IL-2RP, which shares only minimal
sequence identities with Epo-R, can substitute for Epo-R in
promoting cell growth when coexpressed with viral glyco-
proteins. Although we have so far failed to show a direct
binding of IL-2R,B by the viral glycoproteins in a double-IP
assay, there may still be a direct interaction between the two
proteins which is not as strong as that between the glyco-
proteins and Epo-R and which is disrupted under the condi-
tions of our IP assay. Indeed, the observation that the
growth of virus-infected Ba/F-12 cells has a density require-
ment might suggest that a weak interaction between IL-2RP
and the glycoproteins is facilitated by close cell-cell contact.
Of all the members in the Epo-R-IL-2RP family, including
the receptors for human growth hormone, rabbit prolactin,
granulocyte-macrophage colony stimulating factor, IL-3,
IL-4, IL-6, and IL-7 (4, 19), Epo-R is most closely related to
IL-2RP (18). It is unlikely that the recombinant-type viral
glycoproteins can interact with all members of this receptor
family. The receptor for IL-3 in Ba/F3 cells, for example, is
probably not bound by the viral glycoproteins because
infection with either MCF viruses (Table 1) or SFFV (39)
does not convert Ba/F3 cells to growth factor independence.
A receptor-mediated model was previously proposed for
virus-induced leukemogenesis (45, 46). Here we suggest that
the model was fundamentally correct except that it is a
hormone receptor, rather than an antigen receptor, that
mediates the leukemogenic process.
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